Completed NA INTERVENTIONAL 2-arm NCT01739543

A Reduction in C-section Rates Using the Hem-Avert Perianal Stabilizer

Sponsor: Stetrix, Inc.

Conditions Complications; Cesarean Section

Interventions Hem-Avert

Updated 6 times since 2017 Last updated: Mar 14, 2013 Started: Apr 30, 2012 Primary completion: Jan 31, 2013 Completion: Jan 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01739543, this NA trial focuses on Complications; Cesarean Section and remains completed. Sponsored by Stetrix, Inc., it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
May 2020 — Jan 2021 [monthly]

Completed NA
Jun 2018 — May 2020 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Apr 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Stetrix, Inc.

Data source: Stetrix, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Niagara Falls, United States